Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
Clinical trial NCT07311746 · RECRUITING
Trial details
- NCT number
- NCT07311746
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-28
- Primary completion
- 2029-01-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.